盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002864 盘龙药业

已收盘 12-12 15:00:00

{"stockData":{"symbol":"002864","market":"SZ","secType":"STK","nameCN":"盘龙药业","latestPrice":32,"timestamp":1765522992000,"preClose":32.72,"halted":0,"volume":4519175,"delay":0,"changeRate":-0.022,"floatShares":74190700,"shares":106000000,"eps":1.1339,"marketStatus":"已收盘","change":-0.72,"latestTime":"12-12 15:00:00","open":32.5,"high":32.64,"low":31.87,"amount":146000000,"amplitude":0.0235,"askPrice":32.01,"askSize":26,"bidPrice":32,"bidSize":89,"shortable":0,"etf":0,"ttmEps":1.1339,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":32.72,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":35.99,"lowLimit":29.45,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":106280960,"isCdr":false,"pbRate":2.07,"roa":"--","peRate":28.221184,"roe":"5.39%","epsLYR":1.15,"committee":0.639423,"marketValue":3401000000,"turnoverRate":0.0609,"status":1,"floatMarketCap":2374000000},"requestUrl":"/m/hq/s/002864/tweets","defaultTab":"tweets","newsList":[{"id":"2590318473","title":"盘龙药业：抗流感药品已在市场销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2590318473","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590318473?lang=zh_cn&edition=full","pubTime":"2025-12-09 15:15","pubTimestamp":1765264526,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业12月09日在投资者关系平台上答复投资者关心的问题。另外，针对这次流感，公司有没有调整生产计划，或者加大这些药品的生产力度？上述产品均已在市场销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900018265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2588667010","title":"盘龙药业：连续两年获得“上市公司ESG价值传递奖”","url":"https://stock-news.laohu8.com/highlight/detail?id=2588667010","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588667010?lang=zh_cn&edition=full","pubTime":"2025-12-03 18:40","pubTimestamp":1764758401,"startTime":"0","endTime":"0","summary":"在同期举办的“易董ESG价值评级”颁奖典礼上，盘龙药业获得“2025年度上市公司ESG价值传递奖”，这是该企业连续第二年获得此项荣誉。“ESG价值传递奖”是资本市场极具公信力与影响力的重要奖项，旨在表彰在ESG理念传播、社会责任深度践行、投资者关系高效管理等方面表现突出的上市企业。盘龙药业表示，未来公司将进一步深化ESG价值创造与传递工作，通过更扎实的责任实践、更透明的信息披露、更创新的ESG举措，持续提升企业综合竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251203/31842068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","159717","002864","ESG"],"gpt_icon":0},{"id":"2583579029","title":"11月14日盘龙药业（002864）龙虎榜数据：机构净卖出5509.54万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583579029","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583579029?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:33","pubTimestamp":1763112784,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月14日公布的交易公开信息显示，盘龙药业因日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年11月14日收盘，盘龙药业报收于38.62元，下跌1.48%，换手率38.79%，成交量28.78万手，成交额11.59亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出5509.54万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400028258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2583468955","title":"【机构调研记录】银河基金调研盘龙药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2583468955","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583468955?lang=zh_cn&edition=full","pubTime":"2025-11-14 08:05","pubTimestamp":1763078735,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月13日披露的机构调研信息，银河基金近期对1家上市公司进行了调研，相关名单如下：1）盘龙药业 调研纪要：公司以盘龙七片为主导，拥有4个独家品种及多项自主知识产权产品，涵盖12大功能类别、100多个品规。银河基金成立于2002年，截至目前，资产管理规模1080.23亿元，排名57/211；资产管理规模782.31亿元，排名55/211；管理公募基金数153只，排名50/211；旗下公募基金经理24人，排名60/211。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400005543.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2583565001","title":"盘龙药业：改良型新药进入临床阶段，“口服+外用”拓展增量市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2583565001","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583565001?lang=zh_cn&edition=full","pubTime":"2025-11-13 18:30","pubTimestamp":1763029801,"startTime":"0","endTime":"0","summary":"盘龙药业一款重磅改良型创新药进入临床阶段！日前，盘龙药业发布公告称，公司近日收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，盘龙七凝胶贴膏获准开展膝骨关节炎的临床试验。根据公司披露，2025年前三季度，盘龙药业实现营收8.41亿元，同比增长17.37%，归母净利润8981万元，同比增长0.26%。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202511/13/20251113430205.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202511/13/20251113430205.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251113/31793149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2583853558","title":"“吃药”行情归来？4600亿巨头成功扭亏，港A创新药全线沸腾","url":"https://stock-news.laohu8.com/highlight/detail?id=2583853558","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583853558?lang=zh_cn&edition=full","pubTime":"2025-11-13 14:18","pubTimestamp":1763014725,"startTime":"0","endTime":"0","summary":"机构：中国创新药产业已进入2.0时代","market":"hk","thumbnail":"https://static.tigerbbs.com/a9cdeabfc0af4ed4ad7c24a7818b7af3","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a9cdeabfc0af4ed4ad7c24a7818b7af3"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f6068c36e82c4ed544af336a63a9d021","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/3190454","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1191","IE00BZ08YT58.USD","BK0239","300584","300497","BK1141","BK0201","BK1161","06978","BK1589","002864","BK1521","HK0000165453.HKD","688382","IE00BZ08YR35.GBP","02268","01672","01177","SG9999014674.SGD","LU2488822045.USD","BK1515","BK1574","IE00BZ08YS42.EUR"],"gpt_icon":1},{"id":"2582323323","title":"盘龙药业(002864.SZ)：盘龙七凝胶贴膏获批开展用于膝骨关节炎临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2582323323","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582323323?lang=zh_cn&edition=full","pubTime":"2025-11-12 16:04","pubTimestamp":1762934648,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盘龙药业(002864.SZ)发布公告，近日，公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意盘龙七凝胶贴膏开展用于膝骨关节炎的临床试验。盘龙七凝胶贴膏是由盘龙七药酒(国药准字Z61021120)改良而来，处方由盘龙七、壮筋丹等30味药材组成，开发成凝胶贴膏剂，该产品较原剂型在使用便捷性、起效速度、使用人群等方面均有明显优势，其主治功能为活血化瘀、祛风除湿、消肿止痛。适用于膝骨关节炎(气滞血瘀证)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1368234.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2582312779","title":"异动快报：盘龙药业（002864）11月12日9点52分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2582312779","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582312779?lang=zh_cn&edition=full","pubTime":"2025-11-12 09:55","pubTimestamp":1762912540,"startTime":"0","endTime":"0","summary":"证券之星11月12日盘中消息，9点52分盘龙药业触及涨停板。目前价格34.72，上涨7.16%。其所属行业中药目前上涨。领涨股为特一药业。该股为创新药，中药，医药概念热股，当日创新药概念上涨0.97%，中药概念上涨0.9%，医药概念上涨0.89%。11月11日的资金流向数据方面，主力资金净流出161.57万元，占总成交额1.72%，游资资金净流出239.43万元，占总成交额2.54%，散户资金净流入400.99万元，占总成交额4.26%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200008915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2578939133","title":"盘龙药业(002864)9月30日股东户数2.09万户，较上期减少10.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578939133","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578939133?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:36","pubTimestamp":1761644189,"startTime":"0","endTime":"0","summary":"证券之星消息，近日盘龙药业披露，截至2025年9月30日公司股东户数为2.09万户，较6月30日减少2538.0户，减幅为10.84%。在中药行业个股中，盘龙药业股东户数低于行业平均水平，截至9月30日，中药行业平均股东户数为5.36万户。从股价来看，2025年6月30日至2025年9月30日，盘龙药业区间涨幅为4.84%，在此期间股东户数减少2538.0户，减幅为10.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800031964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2578655627","title":"图解盘龙药业三季报：第三季度单季净利润同比下降0.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578655627","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578655627?lang=zh_cn&edition=full","pubTime":"2025-10-28 02:58","pubTimestamp":1761591525,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业2025年三季报显示，公司主营收入8.41亿元，同比上升17.37%；归母净利润8980.59万元，同比上升0.26%；扣非净利润8247.01万元，同比上升2.33%；其中2025年第三季度，公司单季度主营收入2.67亿元，同比上升2.24%；单季度归母净利润2967.07万元，同比下降0.83%；单季度扣非净利润2961.26万元，同比下降0.82%；负债率29.79%，投资收益-17.42万元，财务费用-1268.74万元，毛利率52.69%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800002332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864"],"gpt_icon":0},{"id":"2578065008","title":"股市必读：盘龙药业（002864）10月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2578065008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578065008?lang=zh_cn&edition=full","pubTime":"2025-10-27 05:58","pubTimestamp":1761515896,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，盘龙药业报收于31.43元，上涨0.42%，换手率5.02%，成交量3.73万手，成交额1.17亿元。董秘最新回复投资者： 董秘您好，公司有生产和销售抗流感药品吗？交易信息汇总资金流向10月24日主力资金净流出139.59万元；游资资金净流出181.43万元；散户资金净流入321.02万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700001678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2577593056","title":"盘龙药业：生产销售抗流感药品","url":"https://stock-news.laohu8.com/highlight/detail?id=2577593056","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577593056?lang=zh_cn&edition=full","pubTime":"2025-10-24 16:30","pubTimestamp":1761294648,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业10月24日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400028524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2574169046","title":"盘龙药业（002864）披露变更持续督导保荐代表人公告，10月9日股价下跌0.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574169046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574169046?lang=zh_cn&edition=full","pubTime":"2025-10-09 23:04","pubTimestamp":1760022257,"startTime":"0","endTime":"0","summary":"截至2025年10月9日收盘，盘龙药业报收于29.4元，较前一交易日下跌0.47%，最新总市值为31.25亿元。该股当日开盘29.64元，最高29.65元，最低29.1元，成交额达5329.22万元，换手率为2.45%。公司近日发布公告称，陕西盘龙药业集团股份有限公司于近日收到中泰证券出具的关于变更持续督导保荐代表人的报告。公司董事会对王彦忠在持续督导期间所做工作表示感谢。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900034984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2571772608","title":"盘龙药业：高端仿制药领域实现零的突破，强势叩开化药市场大门","url":"https://stock-news.laohu8.com/highlight/detail?id=2571772608","media":"中金财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571772608?lang=zh_cn&edition=full","pubTime":"2025-09-29 11:20","pubTimestamp":1759116001,"startTime":"0","endTime":"0","summary":"近日，盘龙药业传来重磅消息——其在研产品洛索洛芬钠凝胶贴膏收到国家药监局下发的仿制药上市许可申请《受理通知书》。这不仅标志着盘龙药业在化药高端仿制药领域实现零的突破，更成为企业发展过程中具有划时代意义的关键节点。齐华锋同时透露，后续盘龙药业将围绕风湿骨病领域，陆续推出多款凝胶贴膏产品。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202509/29/20250929314401.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202509/29/20250929314401.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20250929/31680368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2571824886","title":"股市必读：盘龙药业（002864）9月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2571824886","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571824886?lang=zh_cn&edition=full","pubTime":"2025-09-29 03:57","pubTimestamp":1759089430,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，盘龙药业报收于29.3元，下跌0.41%，换手率2.48%，成交量1.84万手，成交额5381.44万元。董秘最新回复投资者： 董秘，你好，为何不正面回答之前在互动易投资者询问的：为支持西渝高铁建设，公司拆除了原职工宿舍，是否有货币补偿这个问题？如果有货币补偿会不会在第三季度报告里有所体现董秘： 尊敬的投资者您好！当日关注点来自交易信息汇总：9月26日主力资金净流出6.6万元，散户资金净流入422.95万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900001438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002864","BK0239"],"gpt_icon":0},{"id":"2570008643","title":"盘龙药业(002864.SZ)：PLJT-001洛索洛芬钠凝胶贴膏获境内生产药品注册上市许可受理通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2570008643","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570008643?lang=zh_cn&edition=full","pubTime":"2025-09-26 16:19","pubTimestamp":1758874779,"startTime":"0","endTime":"0","summary":"智通财经APP讯，盘龙药业 发布公告，近日，公司在研产品洛索洛芬钠凝胶贴膏收到国家药品监督管理局下发的仿制药上市许可申请《受理通知书》。洛索洛芬钠凝胶贴膏，为治疗骨关节炎、肌肉痛、外伤后的肿胀或疼痛的凝胶贴膏。PLJT-001中有效成分为洛索洛芬钠，苯丙酸类非甾体抗炎药，具有显著的抗炎镇痛作用，尤其是镇痛作用较强。洛索洛芬钠为前体药物，经皮肤吸收后，转变为活性代谢物反式-OH体发挥作用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349848.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"盘龙药业(002864.SZ)：PLJT-001洛索洛芬钠凝胶贴膏获境内生产药品注册上市许可受理通知书","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2570081401","title":"股市必读：盘龙药业（002864）9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2570081401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570081401?lang=zh_cn&edition=full","pubTime":"2025-09-25 01:34","pubTimestamp":1758735254,"startTime":"0","endTime":"0","summary":"截至2025年9月24日收盘，盘龙药业报收于29.83元，上涨0.81%，换手率2.96%，成交量2.19万手，成交额6519.0万元。董秘最新回复投资者： 董秘你好，公司有意愿溢价收购实控人名下的房地产企业吗？公司所有的投资与收购行为均严格遵循法律法规及公司章程的规定，以公平、公正的市场原则为基础进行审慎决策。如有相关进展，公司将严格按照监管要求及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500000701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2569281727","title":"盘龙药业：拟购置新楼作为生产基地员工公寓","url":"https://stock-news.laohu8.com/highlight/detail?id=2569281727","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569281727?lang=zh_cn&edition=full","pubTime":"2025-09-24 09:12","pubTimestamp":1758676344,"startTime":"0","endTime":"0","summary":"证券之星消息，盘龙药业09月23日在投资者关系平台上答复投资者关心的问题。公司的愿景是“让百姓吃上放心药，让员工过上好日子”，公司为妥善解决生产基地员工的住宿需求，拟购置新楼作为公司专门的生产基地员工公寓。具体情况可详见公司于2025年9月20日在巨潮资讯网披露的《关于购买资产暨关联交易的公告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092400009298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2567414827","title":"盘龙药业：选举朱文锋为第五届董事会职工代表董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2567414827","media":"证券日报网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567414827?lang=zh_cn&edition=full","pubTime":"2025-09-15 22:10","pubTimestamp":1757945400,"startTime":"0","endTime":"0","summary":"证券日报网讯9月15日晚间，盘龙药业发布公告称，公司于2025年9月12日在公司会议室召开职工代表大会，经与会职工代表民主选举，同意朱文锋先生为公司第五届董事会职工代表董事。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-15/doc-infqqytz4310090.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-15/doc-infqqytz4310090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002864"],"gpt_icon":0},{"id":"2565456827","title":"盘龙药业：9月10日将举行2025年半年度网上业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2565456827","media":"证券日报网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565456827?lang=zh_cn&edition=full","pubTime":"2025-09-05 19:39","pubTimestamp":1757072340,"startTime":"0","endTime":"0","summary":"证券日报网讯9月5日晚间，盘龙药业发布公告称，公司将于2025年9月10日(星期三)15：00-17：00举行2025年半年度网上业绩说明会。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-05/doc-infpmzef7593151.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-05/doc-infpmzef7593151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","002864"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765735055296,"stockEarnings":[{"period":"1week","weight":-0.0831},{"period":"1month","weight":-0.1021},{"period":"3month","weight":0.0803},{"period":"6month","weight":0.1305},{"period":"1year","weight":0.0282},{"period":"ytd","weight":0.0671}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"陕西盘龙药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20868人(较上一季度减少10.84%)","perCapita":"3555股","listingDate":"2017-11-16","address":"陕西省商洛市柞水县盘龙生态产业园","registeredCapital":"10628万元","survey":"　　陕西盘龙药业集团股份有限公司的主营业务是药材规范化种植、药品生产、研发、销售和医药物流。公司的主要产品是盘龙七片、盘龙七药酒、金茵利胆胶囊和克比热提片，以及复方醋酸棉酚片、醋酸棉酚原料药。公司荣获多项荣誉，其中盘龙药业荣获“国家级绿色工厂”、第七届“全国文明单位”，盘龙生态产业园获“陕西省中医药文化宣传教育基地”，并成功取得中国合格评定国家认可委员会（CNAS）实验室认可证书。","listedPrice":10.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"盘龙药业,002864,盘龙药业股票,盘龙药业股票老虎,盘龙药业股票老虎国际,盘龙药业行情,盘龙药业股票行情,盘龙药业股价,盘龙药业股市,盘龙药业股票价格,盘龙药业股票交易,盘龙药业股票购买,盘龙药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"盘龙药业(002864)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供盘龙药业(002864)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}